Advertisement
News
Subscribe to MDT Magazine News

Quest Diagnostics closes Athena Diagnostics deal

April 4, 2011 5:45 am | by The Associated Press | Comments

Quest Diagnostics Inc. said Monday it has completed its $740 million purchase of Thermo Fisher Scientific Inc.'s Athena Diagnostics business.Athena Diagnostics focuses on diagnostic tests for neurological conditions, including Alzheimer's disease. Quest agreed to buy the Worcester, Mass.,...

Vitamin D can decrease -- or increase -- breast cancer development and insulin resistance

April 4, 2011 5:39 am | by EurekAlert | Comments

(Georgetown University Medical Center) In mice models of breast cancer, researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, found that vitamin D significantly reduced development of estrogen receptor-positive (ER+)...

TOPICS:

NMT Medical: Not enough cash to fill annual report

April 4, 2011 5:39 am | by Mass High Tech: The Journal of New England Technology | Comments

More bad news for cardiac implant maker NMT Medical Inc., as it filed last week federal documents stating it does not have enough money on hand to file its annual report for 2010.

Advertisement

Hologic to Release Second Quarter Fiscal 2011 Operating Results on Monday, May 2, 2011

April 4, 2011 5:34 am | by Bio-Medicine.Org | Comments

BEDFORD, Mass., April 4, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to...

TOPICS:

Medstreaming Launches Fully Integrated Cardiovascular PACS and Certified EMR With Electronic Whiteboard at ACC

April 4, 2011 5:34 am | by Bio-Medicine.Org | Comments

NEW ORLEANS, April 4, 2011 /- Medstreaming, a leading provider of medical IT solutions, announced today the launch of a fully integrated Cardiovascular PACS and certified EMR with a web-based Cardiovascular Electronic Whiteboard.  With the introduction of these components...

TOPICS:

superDimension Receives FDA 510(k) Clearance for Marker Delivery Kit

April 4, 2011 5:34 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, April 4, 2011 /- superDimension, Ltd. ® , a privately-owned company that develops minimally invasive interventional pulmonology devices, today announced it has received FDA 510(k) clearance for the superDimension marker delivery kit. The kit is designed for use with the...

TOPICS:

Aspirin May Lower the Risk of Pancreatic Cancer

April 4, 2011 5:34 am | by AACR | Comments

Tweet • Benefit was seen with aspirin, but not non-aspirin NSAIDs. • Effect was also present in people who took low-dose aspirin for heart disease prevention. • Patients should consult doctors before taking aspirin as a preventive agent. ORLANDO, Fla. - The use of aspirin at least once...

TOPICS:

Lung Cancer Risk Rises in the Presence of HPV Antibodies

April 4, 2011 5:34 am | by AACR | Comments

Tweet • Carcinogenic role of HPV in lung cancer is being examined. • Study results were similar regardless of gender and smoking history. • Question of a causal relationship between HPV and lung cancer remains. ORLANDO, Fla. - Researchers with the International Agency for Research on...

TOPICS:
Advertisement

Nicotine Does Not Promote Lung Cancer Growth in Mouse Models

April 4, 2011 5:33 am | by AACR | Comments

Tweet • Nicotine replacement therapy is not linked to tumor incidence, size. • Long-term therapeutic use may help people with nicotine addiction. ORLANDO, Fla. - Nicotine at doses similar to those found in most nicotine replacements therapies did not increase lung cancer tumor incidence,...

TOPICS:

Breast Milk May Provide a Personalized Screen of Breast Cancer Risk

April 4, 2011 5:33 am | by AACR | Comments

Tweet • Breast cancer is difficult to detect during pregnancy and lactation. • Breast milk screening may be more accurate than conventional screening. • Abstract presented during an AACR press conference. ORLANDO, Fla. - Breast cancer risk can be assessed by examining the epithelial cells...

TOPICS:

Serum Test Could Identify Lung Cancer in People Who Never Smoked

April 4, 2011 5:33 am | by AACR | Comments

Tweet • Biomarker panel in serum has 83 percent sensitivity/specificity. • As many as 25 percent of lung cancer patients have never smoked. ORLANDO, Fla. - A panel of biomarkers appears to be able to identify the presence of lung cancer in the blood samples of people who have never...

TOPICS:

Protein Test Detects Early-stage, Asbestos-related Pulmonary Cancer

April 4, 2011 5:33 am | by AACR | Comments

Tweet • Test measures 19 biomarkers of malignant pleural mesothelioma. • Novel biomarker test may be the most accurate yet. ORLANDO, Fla. - Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to...

TOPICS:

Mylan Receives Approval for Generic Version of Xalatan® Ophthalmic Solution

April 4, 2011 4:35 am | by Bio-Medicine.Org | Comments

PITTSBURGH, April 4, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Latanoprost Ophthalmic Solution, 0.005%,...

TOPICS:

OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals

April 4, 2011 3:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 4, 2011 /- OncoSec Medical Incorporated (OTCBB: ONCS), a developer of innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today that on March 24, 2011 it completed its acquisition of certain assets of Inovio Pharmaceuticals, Inc....

TOPICS:

NeuroSigma, Inc. Retains CCG Investor Relations

April 4, 2011 3:32 am | by Bio-Medicine.Org | Comments

LOS ANGELES, April 4, 2011 /- NeuroSigma, Inc. ("NeuroSigma"), a Los Angeles-based medical technology company established to in-license and develop early stage technologies with the potential to transform medical practice, today announced that it has retained CCG Investor Relations to...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading